Business Continuity Plan in Action 2007 Alison Turner General Manager National Blood Authority 28 Feb 2008
A Culture of Risk Management
The NBA Established following a review of the blood sector 2003 National Blood Agreement States/ Territories / Commonwealth National approach to supply/ production / contingency planning
The NBA Civic, Canberra, 50 staff O6/07 Annual Operating Budget $10m 06/07 spent $625.8m on blood products Around $325m for ARCBS Around $295m for plasma and recombinant products, inc $150m imported
Scope of the NBA Nationally plan, predict, buy & manage All fresh blood products (through the ARCBS) All plasma and recombinant products Risk and contingency planning Influence appropriate use at a clinical level though partnerships
What We Get From Blood Clotting Factors (inc pviii) Plasma Local manufacture Whole Blood Red Cells Albumin Platelets Immunoglobulins (inc IVIg) Overseas Manufacture Recombinant Clotting Factors
Examples of major blood supply /demand risks Whole Blood Inadequate donors Ineligible donors Plant failure (few global sites) Recombinant Clotting Factors Reaches regulatory standard Clotting Factors (inc pviii) Burns patients Contamination Manufacturing fault Manufacture Albumin Immunoglobulins (inc IVIg) Inadequate blood collected Inadequate collections (expiry) Platelets
Examples of risk mitigation Whole Blood Donation promotion Multiple suppliers In country reserves Recombinant Clotting Factors Importation Manage demand Clotting Factors (inc pviii) Product reserves Multiple suppliers Contract requirements Manufacture Albumin Immunoglobulins (inc IVIg) Importation Authorisation of use Clinical guidelines Platelets
NBA s Risk policy Development Modification of best practice example based on AS/NZS 4360:2004 Challenge was to: Create framework suitable for small agency Understand our risks What implications did our unique governance have Understand sector risks Limited knowledge, skills or experience in the subject manner Embed risk assessment in our culture Not just policy, not just programs but real doing
Practical outputs then Key Business Processes #1 Risk Blood sector Crisis Management Plan Plasma and recombinant product contingency plan Interim Emergency Blood Management Plan Business Continuity Plan
Principles 2003+ Analyse Plan Implement Communicate Monitor Review
Developing Our Business Continuity Plan Business Impact Analysis - Consultation with staff and stakeholders Risk Treatment - Risk mitigation strategies for key business processes Documentation - Roles and Responsibilities - Escalation procedures Training
Short Term Results Business obligations met New international supply arrangements negotiated that day All business functions operational within 14 hours Staff kept well informed Stakeholders kept advised at all times
Short Term Results Existing premises restored Comcover requirements met Financial commitments met Accountability and good business practices maintained
Long Term Benefits Competencies in disaster management and accountability Credibility enhanced with stakeholders Experience in implementing contingency plans Flexible working arrangements endured Strengthening of NBA teams Simple, practical and targeted improvements made to BCP
Long Term Benefits Roles clarified to enhance responsiveness and flexibility Improved IT recovery processes Staff acknowledge management responsiveness Reinforced need to plan for serious events No need to run trial of BCP!
The best and the worst. Worst preparation up to date contact details for all staff Best assets after NBA people 2 server boxes with staff my house with broadband relationships with stakeholders/ suppliers Good BCP (or course!) Best decisions - rental premises quickly - allowance for staff
Practical Outputs Now Key Business Process on Risk - V4 Business Continuity Plan - V2 Blood Sector wide contingency plans Engagement in health sector contingency planning
Evolution of our risk Principles In the beginning: - Analyse/Plan/Implement/Communicate/ Monitor /Review NOW Leadership Credibility Engagement Communication Reform
Scenario your 78 year old mother is in hospital having had a hip replacement and the surgeon suggests that some blood would pep her up. Her red cell count is only a little bit below normal and would normally improve over the next 2-6 weeks Should your mother have the transfusion? What are the main risks? AIDS? Hepatitis B?
Blood sector reform a precautionary approach to transfusion The biggest risk with blood is that they will mix up things in the hospital and you may end up with the wrong blood Alternatively, you may get a fever or have problems due to too much blood too quickly You are highly unlikely to get AIDS (1 in 10m) BUT in the case described you are probably more likely to do better in the longer term by not getting the transfusion Always ask the doctor if the blood is REALLY essential
Thank you www.nba.gov.au